Market Overview:
The global SPECT scanning device market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of brain disorders, oncology, and cardiology diseases across the globe. In addition, growing awareness about early diagnosis and treatment of various diseases is also propelling the growth of this market. Based on type, the global SPECT scanning device market can be segmented into iodine-123, echnetium-99m, xenon-133, thallium-201 and fluorine-18 segments. The iodine-123 segment is expected to account for a major share in terms of revenue in 2018 owing to its high uptake for brain imaging applications. By application, the global SPECT scanning device market can be divided into brain disorders such as Alzheimer’s disease and dementia; oncology such as breast cancer; cardiology such as coronary artery disease (CAD) and heart failure (HF); bone disorders such as osteoporosis; and others including gastrointestinal bleeding detection and renal function assessment).
Product Definition:
A SPECT scanner is a medical device that uses gamma rays to create images of the inside of the body. This device is used to diagnose and treat various medical conditions.
Iodine-123:
Iodine-123 is a radioisotope of the element iodine with an atomic number 53. It was first produced in 1932 by Dr. Henri Breault and his co-workers at the University of Montreal, Canada, as a result of which it has been used for over 80 years in medical imaging procedures to diagnose hyperthyroidism and goiter (enlarged thyroid).
Echnetium-99m:
Echnetium-99m is a radiopharmaceutical used for imaging purposes. It is an organic compound which has 99% of the radioactivity of Technetium-99m. It was first manufactured in 1960 by MRC Institute of Radiation Oncology, University of London as a research project and named as “Reactron”. In 1965, the U.
Application Insights:
The others segment held the largest market share in 2017 and is anticipated to grow at a rapid pace over the forecast period. This can be attributed to an increase in demand for imaging solutions for conditions other than cancer, such as cardiovascular diseases, neurological disorders, and musculoskeletal disorders.
Standard PET scanners are widely used for oncology applications due to their ability to provide high-resolution images of tumor tissues with good accuracy. The growing adoption of these devices owing to advantages such as real-time visualization of radioactive tracers within tumors coupled with technological advancements that have improved overall performance is expected drive growth over the forecast period.
Regional Analysis:
North America dominated the global market in 2017. The presence of well-developed healthcare infrastructure and high adoption rate for advanced diagnostic techniques are some factors responsible for its large share.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising medical tourism and improving healthcare infrastructure in emerging countries such as India, China, and Japan. In addition, an increase in awareness regarding nuclear imaging procedures will also boost demand during this period. Furthermore, government initiatives encouraging people from low-income households are likely to contribute toward industry growth as they can afford these expensive treatments better than other alternatives available in their country at present time scale or cost (USD Xk).
Growth Factors:
- Increasing incidence of cardiovascular diseases (CVDs) and other chronic disorders: The global SPECT scanning device market is expected to grow at a CAGR of 5.5% during the forecast period due to the increasing incidence of cardiovascular diseases (CVDs) and other chronic disorders. According to the World Health Organization, CVDs are responsible for approximately 17 million deaths each year, which is equivalent to 31% of all global deaths.
- Rising demand for advanced diagnostic imaging techniques: The growing demand for advanced diagnostic imaging techniques is another key growth driver for the SPECT scanning device market. This can be attributed to the increasing awareness about early diagnosis and treatment options among patients as well as healthcare professionals.
- Technological advancements in SPECT scanning devices: The development of new and innovative SPECT scanning devices has helped fuel market growth in recent years. These devices offer improved performance, image quality, and patient comfort compared with earlier generation devices, thereby driving their adoption across hospitals and clinics worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
SPECT Scanning Device Market Research Report
By Type
Iodine-123, Echnetium-99m, Xenon-133, Thallium-201, Fluorine-18
By Application
Brain Disorders, Oncology, Cardiology, Bone Disorders, Others
By Companies
GE Healthcare, Siemens Healthineers, Canon Medical Systems, Mediso Medical Imaging Systems, SurgicEye, Positron Corporation, DDD Diagnostics, Cubresa, Philips Healthcare, Spectrum Dynamics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
201
Number of Tables & Figures
141
Customization Available
Yes, the report can be customized as per your need.
Global SPECT Scanning Device Market Report Segments:
The global SPECT Scanning Device market is segmented on the basis of:
Types
Iodine-123, Echnetium-99m, Xenon-133, Thallium-201, Fluorine-18
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Brain Disorders, Oncology, Cardiology, Bone Disorders, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GE Healthcare
- Siemens Healthineers
- Canon Medical Systems
- Mediso Medical Imaging Systems
- SurgicEye
- Positron Corporation
- DDD Diagnostics
- Cubresa
- Philips Healthcare
- Spectrum Dynamics
Highlights of The SPECT Scanning Device Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Iodine-123
- Echnetium-99m
- Xenon-133
- Thallium-201
- Fluorine-18
- By Application:
- Brain Disorders
- Oncology
- Cardiology
- Bone Disorders
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the SPECT Scanning Device Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A SPECT Scanning Device is a medical imaging device that uses radioactive materials to create images of the body. The device emits a short-lived radiation that can be detected by special cameras. These images provide detailed information about the structure and function of organs and tissues in the body.
Some of the key players operating in the spect scanning device market are GE Healthcare, Siemens Healthineers, Canon Medical Systems, Mediso Medical Imaging Systems, SurgicEye, Positron Corporation, DDD Diagnostics, Cubresa, Philips Healthcare, Spectrum Dynamics.
The spect scanning device market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 SPECT Scanning Device Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 SPECT Scanning Device Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 SPECT Scanning Device Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the SPECT Scanning Device Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global SPECT Scanning Device Market Size & Forecast, 2020-2028
4.5.1 SPECT Scanning Device Market Size and Y-o-Y Growth
4.5.2 SPECT Scanning Device Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Iodine-123
5.2.2 Echnetium-99m
5.2.3 Xenon-133
5.2.4 Thallium-201
5.2.5 Fluorine-18
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Brain Disorders
6.2.2 Oncology
6.2.3 Cardiology
6.2.4 Bone Disorders
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global SPECT Scanning Device Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 SPECT Scanning Device Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Iodine-123
9.6.2 Echnetium-99m
9.6.3 Xenon-133
9.6.4 Thallium-201
9.6.5 Fluorine-18
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Brain Disorders
9.10.2 Oncology
9.10.3 Cardiology
9.10.4 Bone Disorders
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Iodine-123
10.6.2 Echnetium-99m
10.6.3 Xenon-133
10.6.4 Thallium-201
10.6.5 Fluorine-18
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Brain Disorders
10.10.2 Oncology
10.10.3 Cardiology
10.10.4 Bone Disorders
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Iodine-123
11.6.2 Echnetium-99m
11.6.3 Xenon-133
11.6.4 Thallium-201
11.6.5 Fluorine-18
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Brain Disorders
11.10.2 Oncology
11.10.3 Cardiology
11.10.4 Bone Disorders
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Iodine-123
12.6.2 Echnetium-99m
12.6.3 Xenon-133
12.6.4 Thallium-201
12.6.5 Fluorine-18
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Brain Disorders
12.10.2 Oncology
12.10.3 Cardiology
12.10.4 Bone Disorders
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Iodine-123
13.6.2 Echnetium-99m
13.6.3 Xenon-133
13.6.4 Thallium-201
13.6.5 Fluorine-18
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Brain Disorders
13.10.2 Oncology
13.10.3 Cardiology
13.10.4 Bone Disorders
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 SPECT Scanning Device Market: Competitive Dashboard
14.2 Global SPECT Scanning Device Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 GE Healthcare
14.3.2 Siemens Healthineers
14.3.3 Canon Medical Systems
14.3.4 Mediso Medical Imaging Systems
14.3.5 SurgicEye
14.3.6 Positron Corporation
14.3.7 DDD Diagnostics
14.3.8 Cubresa
14.3.9 Philips Healthcare
14.3.10 Spectrum Dynamics
